IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
04.08.2025 13:14:38
|
IDEXX Labs Lifts FY25 Outlook Above Market After Q2 Beats Street; Stock Gains In Pre-market
(RTTNews) - IDEXX Laboratories, Inc. (IDXX), while reporting higher second-quarter results above the Street, on Monday raised its outlook for fiscal 2025 earnings and revenues, both above market estimates.
In the pre-market activity on the Nasdaq, IDEXX shares were gaining around 5 percent to trade at $562.11.
For fiscal 2026, the company now expects earnings per share of $12.40 to $12.76, representing a year-over-year growth of 16 percent to 20 percent. The company previously expected earnings per share of $11.93 to $12.43, a growth of 12 percent to 17 percent from last year.
The Wall Street analysts on average expect the company to report earnings of $12.21 per share. Analysts' estimates typically exclude special items.
The revision reflects certain one-time benefits. The updated outlook is 9 percent to 13 percent growth on a comparable basis.
Further, IDEXX updated the lower end of its full-year reported operating margin outlook, and now expects between 31.3 percent and 31.6 percent from previously expected 31.1 percent to 31.6 percent.
Annual revenue guidance range has been lifted to $4.205 billion to $4.280 billion or reported growth of 7.7 percent to 9.7 percent from last year, an increase of $90 million at midpoint. The previous outlook was $4.095 billion to $4.210 billion, or 5.0 percent - 8.0 percent year-over-year growth.
The Street expects revenues of $4.15 billion.
The Company lifted the lower end of outlook for organic revenue growth to 7 percent to 9 percent from previous view of 6 percent to 9 percent.
In the second quarter, IDEXX's net income totaled $293.99 million or $3.63 per share, compared to $203.30 million, or $2.44 per share, last year.
Adjusted earnings of $3.50 per share for the period. Analysts had expected the company to earn $3.30 per share.
The company's revenue for the period rose 10.6 percent to $1.109 billion from $1.003 billion last year. The Street was looking for revenues of $1.07 billion.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 553,40 | 1,43% |
|